These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 10626274)
21. An analysis of respondent-driven sampling with injecting drug users in a high HIV prevalent state of India. Phukan SK; Medhi GK; Mahanta J; Adhikary R; Thongamba G; Paranjape RS; Akoijam BS Harm Reduct J; 2017 Jul; 14(1):41. PubMed ID: 28673303 [TBL] [Abstract][Full Text] [Related]
22. [Prevalence of human immunodeficiency virus and hepatitis C virus, and associated factors among injecting drug users in Catalonia]. Huntington S; Folch C; González V; Meroño M; Ncube F; Casabona J Enferm Infecc Microbiol Clin; 2010 Apr; 28(4):236-8. PubMed ID: 19695744 [TBL] [Abstract][Full Text] [Related]
23. Injection drug users' practices and attitudes toward intervention and potential for reducing the transmission of HIV. McCoy CB; Metsch LR; Page JB; McBride DC; Comerford ST Med Anthropol; 1997 Dec; 18(1):35-60. PubMed ID: 9458667 [TBL] [Abstract][Full Text] [Related]
24. [Evaluation of a pilot study on needle and syringe exchange program among injecting drug users in a community in Guangdong, China]. Lin P; Fan ZF; Yang F; Wu ZY; Wang Y; Liu YY; Ming ZQ; Li WJ; Luo W; Fu XB; Mai XR; Xu RH; Feng WY; He Q Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Sep; 38(5):305-8. PubMed ID: 15498241 [TBL] [Abstract][Full Text] [Related]
25. HIV-1 RNA load in needles/syringes from shooting galleries in Miami: a preliminary laboratory report. Shapshak P; Fujimura RK; Page JB; Segal D; Rivers JE; Yang J; Shah SM; Graham G; Metsch L; Weatherby N; Chitwood DD; McCoy CB Drug Alcohol Depend; 2000 Feb; 58(1-2):153-7. PubMed ID: 10669066 [TBL] [Abstract][Full Text] [Related]
26. [Prevalence of human immunodeficiency virus and risk behaviours among opioid users seen in an emergency room]. Pérez González K; Domingo-Salvany A; Hartnoll R Gac Sanit; 1999; 13(1):7-15. PubMed ID: 10217672 [TBL] [Abstract][Full Text] [Related]
27. Correlates of receptive and distributive needle sharing among injection drug users in Kabul, Afghanistan. Todd CS; Abed AM; Scott PT; Botros BA; Safi N; Earhart KC; Strathdee SA Am J Drug Alcohol Abuse; 2008; 34(1):91-100. PubMed ID: 18161647 [TBL] [Abstract][Full Text] [Related]
28. Syringe access for injection drug users in Rhode Island. Boutwell A; Rich JD Med Health R I; 2004 Jan; 87(1):15-6. PubMed ID: 14989076 [No Abstract] [Full Text] [Related]
29. Needle and syringe sharing practices among injecting drug users in Tehran: a comparison of two neighborhoods, one with and one without a needle and syringe program. Zamani S; Vazirian M; Nassirimanesh B; Razzaghi EM; Ono-Kihara M; Mortazavi Ravari S; Gouya MM; Kihara M AIDS Behav; 2010 Aug; 14(4):885-90. PubMed ID: 18483849 [TBL] [Abstract][Full Text] [Related]
30. Sharing of injection equipment among 3755 intravenous drug users in Valencia, Spain, 1987-1992. Hernández-Aguado I; Ruiz I; Bolumar F; Pérez-Hoyos S; Fernández-García E; Santos C; Torrella A; García de la Hera M; Belda J; Aviñó MJ Int J Epidemiol; 1994 Jun; 23(3):602-7. PubMed ID: 7960389 [TBL] [Abstract][Full Text] [Related]
31. Determinants of current HIV risk behaviour among injecting drug users in Warsaw, Poland. Stark K; Sieroslawski J; Müller R; Wirth D; Godwod-Sikorska C; Bienzle U Eur J Epidemiol; 1996 Jun; 12(3):315-7. PubMed ID: 8884201 [TBL] [Abstract][Full Text] [Related]
32. Client satisfaction and risk behaviours of the users of syringe dispensing machines: a pilot study. Islam M; Stern T; Conigrave KM; Wodak A Drug Alcohol Rev; 2008 Jan; 27(1):13-9. PubMed ID: 18034377 [TBL] [Abstract][Full Text] [Related]
33. Arrests and incarceration of injection drug users for syringe possession in Massachusetts: implications for HIV prevention. Case P; Meehan T; Jones TS J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S71-5. PubMed ID: 9663627 [TBL] [Abstract][Full Text] [Related]
34. Barriers to Access to Sterile Syringes as Perceived by Pharmacists and Injecting Drug Users: Implications for Harm Reduction in Lebanon. Ghaddar A; Nassar K; Elsoury G Subst Use Misuse; 2017 Sep; 52(11):1420-1428. PubMed ID: 28430013 [TBL] [Abstract][Full Text] [Related]
35. New syringe acquisition and multi-person use of syringes among illegal drug users. Richard AJ; Mosier V; Atkinson JS J Public Health Policy; 2002; 23(3):324-43. PubMed ID: 12325289 [TBL] [Abstract][Full Text] [Related]
36. Syringe and needle exchange as HIV/AIDS prevention for injection drug users. Watters JK; Estilo MJ; Clark GL; Lorvick J JAMA; 1994 Jan; 271(2):115-20. PubMed ID: 8264065 [TBL] [Abstract][Full Text] [Related]
37. [Characteristics of intravenous drug users who share injection equipment in Catalonia (Spain)]. Folch C; Casabona J; Brugal MT; Majó X; Meroño M; Espelt A; González V; Gac Sanit; 2012; 26(1):37-44. PubMed ID: 22088906 [TBL] [Abstract][Full Text] [Related]
38. Factors associated with HIV testing among male injecting drug users: findings from a cross-sectional behavioural and biological survey in Manipur and Nagaland, India. Ganju D; Ramesh S; Saggurti N Harm Reduct J; 2016 Jun; 13(1):21. PubMed ID: 27324253 [TBL] [Abstract][Full Text] [Related]
39. Cost and cost-effectiveness of increasing access to sterile syringes and needles as an HIV prevention intervention in the United States. Holtgrave DR; Pinkerton SD; Jones TS; Lurie P; Vlahov D J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S133-8. PubMed ID: 9663636 [TBL] [Abstract][Full Text] [Related]
40. The impact of the needle and syringe-exchange programme in Amsterdam on injecting risk behaviour. Hartgers C; Buning EC; van Santen GW; Verster AD; Coutinho RA AIDS; 1989 Sep; 3(9):571-6. PubMed ID: 2506902 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]